Tonix Pharmaceuticals on the Rise Amid Anticipated FDA Approval

Tonix Pharmaceuticals shares are trading higher after announcing the upcoming FDA decision on its drug TNX-102 SL for fibromyalgia, which could be the first new treatment approved in over 16 years.